Publicacións nas que colabora con Ana Alonso Pérez (6)

2022

  1. Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout

    British Journal of Pharmacology, Vol. 179, Núm. 2, pp. 270-286

  2. Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells

    Biomedicine and Pharmacotherapy, Vol. 155

2020

  1. Caffeine, a risk factor for osteoarthritis and longitudinal bone growth inhibition

    Journal of Clinical Medicine, Vol. 9, Núm. 4

2019

  1. Visfatin as a therapeutic target for rheumatoid arthritis

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 607-618

  2. Visfatin connection: Present and future in osteoarthritis and osteoporosis

    Journal of Clinical Medicine, Vol. 8, Núm. 8

2018

  1. Role of toll-like receptor 4 on osteoblast metabolism and function

    Frontiers in Physiology, Vol. 9, Núm. MAY